Stockreport

Kineta, Inc Transitioning from Nasdaq to OTC Markets [Yahoo! Finance]

Kineta, Inc.  (KA) 
PDF Kineta will continue to pursue strategic alternatives as previously announced TuHURA Biosciences has an exclusivity right and a right of first offer for Kineta's KVA1 [Read more]